From : Jelena Lukic <jlukic@worldbank.org>
To : Nino Patarashvili <npatarashvili@moh.gov.ge>; Nino Kvernadze <ninokvernadze@moh.gov.ge>; Darejan Kapanadze <dkapanadze@worldbank.org>; David Jijelava <djijelava@worldbank.org>
Subject : RE: Georgia COVID-19 project additional financing for vaccines - WB comments on SEP
Cc : tgabunia@moh.gov.ge; Volkan Cetinkaya <vcetinkaya@worldbank.org>; Giorgi Kobaladze <gkobaladze@moh.gov.ge>; Nino V. Moroshkina <nmoroshkina@worldbank.org>; Lia Tavadze <ltavadze@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>
Received On : 08.04.2021 16:21

Dear Nino,

 

Thank you very much for a timely submission of SEP. We hope we will receive the ESMF soon as well.

 

Best, Jelena

 

From: Nino Patarashvili
Sent: Thursday, April 8, 2021 4:07 PM
To: Jelena Lukic ; Nino Kvernadze ; Darejan Kapanadze ; David Jijelava
Cc: tgabunia@moh.gov.ge; Volkan Cetinkaya ; Giorgi Kobaladze ; Nino V. Moroshkina ; Lia Tavadze ; Beka Jakeli
Subject: RE: Georgia COVID-19 project additional financing for vaccines - WB comments on SEP

 

[External]

Dear Jelena,

 

Please find attached file of SEP, updated due to your comments.

 

Best Regards,

 

ნინო პატარაშვილი

სოციალური სტანდარტების სპეციალისტი (კონსულტანტი)

მსოფლიო ბანკის COVID-19-ის წინააღმდეგ სწრაფი რეაგირების პროექტის განმახორციელებელი ჯგუფი (PIU),

საქართველოს ოკუპირებული ტერიტორიებიდან დევნილთა, შრომის, ჯანმრთელობისა და სოციალური დაცვის სამინისტრო

ვებ-გვერდი: www.moh.gov.ge 

ელ ფოსტა: npatarashvili@moh.gov.ge

მობილური: +995 577 382292

 

Nino Patarashvili

Social Standards Specialist (Consultant),

PIU – World Bank Emergency COVID-19 Response Project Implementation Unit

Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia

Web site: www.moh.gov.ge

Email: npatarashvili@moh.gov.ge

Cell: +995 577 382292

 

 

From: Jelena Lukic <jlukic@worldbank.org>
Sent: 1 April, 2021 20:44
To: Nino Kvernadze <ninokvernadze@moh.gov.ge>; Darejan Kapanadze <dkapanadze@worldbank.org>; David Jijelava <djijelava@worldbank.org>
Cc: Tamar Gabunia <tgabunia@moh.gov.ge>; Volkan Cetinkaya <vcetinkaya@worldbank.org>; Nino Patarashvili <npatarashvili@moh.gov.ge>; Giorgi Kobaladze <gkobaladze@moh.gov.ge>; Nino V. Moroshkina <nmoroshkina@worldbank.org>; Lia Tavadze <ltavadze@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>
Subject: RE: Georgia COVID-19 project additional financing for vaccines - WB comments on SEP

 

Dear Nino and colleagues,

 

I have reviewed the draft SEP for AF vaccine. Overall, the document is good. The comments I provided in the attachment serve to enhance its quality and also to address/preempt certain concern which NGO recently raised about WB funded COVID-19 projects. More specifically, NGO carried out a review of SEPs for COVID projects around the world and questioned open consultation process, engagement of vulnerable and minority groups, discourse of SEPs in countries and adequacy of grievance mechanisms to handle GBV/SEA/SH complaints.

 

You will see e that my comments seek to enhance clarity around some of these issues.

 

We are still in the process of reviewing the ESMF. For the sake of time, I suggest that you start addressing comments on SEP.

As you know draft SEP, ESMF and ESCP will need to be disclosed in English and Georgian before the ROC meeting. I would suggest  to start making translation arrangements.

 

Let me know if you have any questions.

 

Best, Jelena

 

From: Nino Kvernadze <ninokvernadze@moh.gov.ge>
Sent: Wednesday, March 31, 2021 7:30 PM
To: Jelena Lukic <jlukic@worldbank.org>; Darejan Kapanadze <dkapanadze@worldbank.org>; David Jijelava <djijelava@worldbank.org>
Cc: tgabunia@moh.gov.ge; Volkan Cetinkaya <vcetinkaya@worldbank.org>; Nino Patarashvili <npatarashvili@moh.gov.ge>; Giorgi Kobaladze <gkobaladze@moh.gov.ge>; Nino V. Moroshkina <nmoroshkina@worldbank.org>; Lia Tavadze <ltavadze@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>
Subject: RE: Georgia COVID-19 project additional financing for vaccines

 

[External]

 

Dear Team,

 

Please find enclosed first drafts of documents for additional Covid-19 vaccine financing.

 

Kind regards,

Nino Kvernadze

 

 

From: Jelena Lukic [mailto:jlukic@worldbank.org]
Sent: Thursday, March 18, 2021 3:50 PM
To: Nino Kvernadze <ninokvernadze@moh.gov.ge>
Cc: Nino Patarashvili <npatarashvili@moh.gov.ge>; Giorgi Kobaladze <gkobaladze@moh.gov.ge>; Darejan Kapanadze <dkapanadze@worldbank.org>; David Jijelava <djijelava@worldbank.org>; Volkan Cetinkaya <vcetinkaya@worldbank.org>; Nino V. Moroshkina <nmoroshkina@worldbank.org>
Subject: RE: Georgia COVID-19 project additional financing for vaccines

 

Dear Nino, dear Colleagues,

 

As a follow up to our previous exchange, I am sharing the following documents which may be helpful when revising the ESMF and SEP to adjust for the vaccine Additional Financing.

 

  1. Template for the ESMF for vaccines projects – please, see the text marked in red – these areas need to be addressed and revised in the existing COVID ESMF
  2. Example of SEP for a vaccine project – please, treat it only as example, so you can see how can the existing COVID SEP be revised to adjust fo the vaccine component. SEP should specifically address the issues that  vaccines reach out to disadvantaged and vulnerable groups after identifying their barriers to access. Stakeholder engagement is key to communicating the principles on fair, equitable and inclusive access and allocation of vaccines, reaching out to disadvantaged and vulnerable groups, overcoming demand-side barriers to access (such as mistrust of vaccines, stigma, cultural hesitancy), and creating accountability against misallocation, discrimination and corruption. These issues should be addressed in detail in a Stakeholder Engagement Plan (SEP), and referenced in the ESMF.

 

The attached Georgia COVID-19 Vaccine deployment plan includes some critical points which should be included/referenced both in the ESMF and SEP.

We would appreciate if you could looks at these documents before our meeting on Monday.

 

Let us know if you have any questions.

 

Best, Jelena

 

From: Nino Kvernadze <ninokvernadze@moh.gov.ge>
Sent: Wednesday, March 17, 2021 4:09 PM
To: Jelena Lukic <jlukic@worldbank.org>
Cc: Nino Patarashvili <npatarashvili@moh.gov.ge>; Giorgi Kobaladze <gkobaladze@moh.gov.ge>; Darejan Kapanadze <dkapanadze@worldbank.org>; David Jijelava <djijelava@worldbank.org>; Volkan Cetinkaya <vcetinkaya@worldbank.org>
Subject: Re: Georgia COVID-19 project additional financing for vaccines

 

[External]

Dear Jelena,

 

Thank you for your email. Proposed date and time is acceptable for us.

 

Quick question, we have already updated the ESMF in accordance with the latest LMP template. Shall we wait for the samples of ESMF&SEP for vaccination projects to finalize ESMF or send the updated one now? 

 

All best,

Nino Kvernadze

 

 

From: Jelena Lukic <jlukic@worldbank.org>
Sent: 17 March 2021 17:16
To: Nino Kvernadze
Cc: Nino Patarashvili; Giorgi Kobaladze; Darejan Kapanadze; David Jijelava; Volkan Cetinkaya
Subject: RE: Georgia COVID-19 project additional financing for vaccines

 

Dear Nino:

Hope all is well. To process this AF for vaccinations, the PIU will need to update the existing ESMF and SEP to reflect the vaccine component.

 

I would suggest to organize meeting on Monday, March 22. Please let us know if PIU E&S team would need to be available on Monday at 2pm TBS time.

 

Darejan and I will send a sample ESMF and SEP for vaccines projects separately. In short, to process this AF, the MoILHSA will need to disclose draft updated  ESMF and SEP in Georgian and English, before Decision Meetings and to carry out consultations and finalize the ESMF and SEP before AF approval.

 

Unlike the original Emergency COVID-19 projects, the AF for vaccines is not processed under emergency procedures, so we need to follow the standard WB processing procedures and complete all ESF documents before AF approval.

 

Hope we can discuss more on Monday.

Best, Jelena

 

 

From: Nino Kvernadze <ninokvernadze@moh.gov.ge>
Sent: Tuesday, March 16, 2021 9:58 PM
To: Volkan Cetinkaya <vcetinkaya@worldbank.org>
Cc: tgabunia@moh.gov.ge; Nino V. Moroshkina <nmoroshkina@worldbank.org>; Jelena Lukic <jlukic@worldbank.org>; ngvenetadze@moh.gov.ge; Nino Patarashvili <npatarashvili@moh.gov.ge>; Lia Tavadze <ltavadze@moh.gov.ge>; Darejan Kapanadze <dkapanadze@worldbank.org>; David Jijelava <djijelava@worldbank.org>; Giorgi Kobaladze <gkobaladze@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Nino Ramishvili <nramishvili@worldbank.org>; Tamar Tsenteradze <ttsenteradze@worldbank.org>; Djamshid Iriskulov <diriskulov@worldbank.org>; Natalie Godziashvili <ngodziashvili@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>
Subject: RE: Georgia COVID-19 project additional financing for vaccines

 

[External]

Dear Volkan,

 

Thank you for your email. We can arrange a meeting anytime soon.

 

I am sure we will have question on E&S requirements for Covid-19 vaccines, given its novelty.  We are glad that Darejan  and Jelena will assist PIU in this important task.

 

Looking forward for our cooperation on the AF of the project!

 

All the best,

Nino Kvernadze

 

 

 

 

From: Volkan Cetinkaya [mailto:vcetinkaya@worldbank.org]
Sent: Tuesday, March 16, 2021 5:46 PM
To: Nino Kvernadze <ninokvernadze@moh.gov.ge>
Cc: Nino V. Moroshkina <nmoroshkina@worldbank.org>; Jelena Lukic <jlukic@worldbank.org>; Nino Gvenetadze <ngvenetadze@moh.gov.ge>; Nino Patarashvili <npatarashvili@moh.gov.ge>; Lia Tavadze <ltavadze@moh.gov.ge>; Darejan Kapanadze <dkapanadze@worldbank.org>; David Jijelava <djijelava@worldbank.org>; Giorgi Kobaladze <gkobaladze@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Nino Ramishvili <nramishvili@worldbank.org>; Tamar Tsenteradze <ttsenteradze@worldbank.org>; Djamshid Iriskulov <diriskulov@worldbank.org>
Subject: Georgia COVID-19 project additional financing for vaccines

 

Dear Nino K. and colleagues in PIU,

 

I hope this email finds you well!

 

We have begun to prepare on additional financing for vaccine under the COVID-19 project and will schedule a meeting with the Ministry and PIU soon to discuss the vaccine deployment plans and next steps.

 

Meantime, our Environmental and Social Specialists, Darejan and Jelena, will reach out to you regarding E&S requirements for the additional financing for vaccines and work closely with you.

 

Please let us know if you have any questions. We are looking forward to working together on this important task!

 

Best,

Volkan